Rafik Fellague-Chebra

Executive Global Group medical Director, Solid tumors franchise, GI cancers Novartis

1. Konferenztag, 02. September 2025

9:20 AM Opening-Keynote: Digital twins: Enabling precision oncology 2.0

-From precision oncology to precision oncology 2.0: How AI and multi-omics integration are redefining individualized care strategies.

-The role of digital twins: Using virtual patient models to simulate disease progression, treatment responses, and predict outcomes.

-Use case in clinical development: Accelerating trial design, patient recruitment, and adaptive protocol optimization through predictive analytics.

-Regulatory and ethical considerations: What needs to be addressed for digital twin models and AI to be clinically validated and adopted.

Check out the incredible speaker line-up to see who will be joining Rafik.

Download The Latest Agenda

In Partnership With:

Pharma IQ

Connect With Us

Questions?

Tel: +49 30 52001534

E-mail: eq@iqpc.de

Iqpc Icon

©2025 IQPC. All rights reserved.

Imprint:
Company information according to § 5 Telemediengesetz
IQPC Gesellschaft für Management Konferenzen mbH
Address: Rosenstrasse 2, 10178 Berlin, Germany
Tel: 49 30 52 001 534
E-mail: info@iqpc.de
Registered at: Amtsgericht Charlottenburg, HRB 76720
VAT-Number: DE210454451
Management: Torben Haagh, Richard A. Worden, Michael R. Worden

Impressum:
Firmeninformationen entsprechend § 5 Telemediengesetz
IQPC Gesellschaft für Management Konferenzen mbH
Adresse: Rosenstrasse 2, 10178 Berlin, Germany
Telefonnummer: 030 52001534
Email Adresse: info@iqpc.de
Registereintragungen: Amtsgericht Charlottenburg HRB 76720
Umsatzsteuer- Indentifikationsnummer DE210454451
Geschäftsführung: Torben Haagh, Richard A. Worden, Michael R. Worden